FNP-223

· Ferrer Internacional S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FNP-223, covering 2025-10-15 to 2025-10-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) [Phase 2]

See pricing